Alpha1-antichymotrypsin and Kallistatin Hydrolysis by Human Cathepsin D
Overview
Chemistry
Authors
Affiliations
In the present paper, we demonstrate that alpha1-antichymotrypsin, a serpin with high inhibitory specificity toward cathepsin G, and kallistatin, a human serpin with high specificity toward tissue kallikrein, are digested by cathepsin D. Alpha1-Antichymotrypsin was hydrolyzed essentially in the reactive center loop at L-S, A-L, or L-V bonds; kallistatin was split into small fragments, but we detected the cleavage at F-F and F-S bonds in its reactive center loop in the first 15 min of digestion. In contrast to alpha1-antichymotrypsin, kallistatin is irreversibly inactivated at pH 4.0. Synthetic internally quenched fluorescent peptides containing sequences similar to the reactive center loops of these serpins were hydrolyzed by cathepsin D. The peptides derived from kallistatin were hydrolyzed more efficiently, and particularly relevant was the high susceptibility of the substrates Abz-AIKFFSAQTNRHILRFNRQ-EDDnp (Km = 0.08 microM, kcat = 2.4 s(-1)) and Abz-AIKFFSAQTNRQ-EDDnp (Km = 0.8 microM, kcat = 17.8 s(-1)), which were hydrolyzed at the F-F bond. Therefore, besides the description of a new class of very efficient internally quenched substrates for cathepsin D, we give evidence for the downregulation role of this proteinase on alpha1-antichymotrypsin and kallistatin. The acidification of extracellular milieu by tumor cells can result in activation of cathepsin D; as a consequence, kinins can be released, improving blood supply and leaving more cathepsin G available for the degradation of extracellular matrix.
Adamantinomatous craniopharyngioma: advances in proteomic research.
Desiderio C, Rossetti D, Castagnola M, Massimi L, Tamburrini G Childs Nerv Syst. 2020; 37(3):789-797.
PMID: 32617710 DOI: 10.1007/s00381-020-04750-z.
Martelli C, Serra R, Inserra I, Rossetti D, Iavarone F, Vincenzoni F Dis Markers. 2019; 2019:3609789.
PMID: 31191748 PMC: 6525946. DOI: 10.1155/2019/3609789.
Song N, Zhao M, Wang Y, Hu X, Wu J, Jiang X Drug Des Devel Ther. 2016; 10:2701-11.
PMID: 27621591 PMC: 5012610. DOI: 10.2147/DDDT.S113804.
Sun H, Lou X, Shan Q, Zhang J, Zhu X, Zhang J PLoS One. 2013; 8(6):e65733.
PMID: 23840360 PMC: 3688724. DOI: 10.1371/journal.pone.0065733.
Ziegler M, Chen T, Leblanc J, Wei X, Gjertson D, Li K Transplantation. 2011; 92(4):388-95.
PMID: 21730889 PMC: 3878300. DOI: 10.1097/TP.0b013e318225db6a.